Certified by Founder
Lodge
HepaRegeniX GmbH
start up
Germany
- Tübingen , Baden-Württemberg
- 16/04/2025
- Unknown
- $24,359,707
HepaRegeniX GmbH is a clinical-stage biotechnology company developing novel therapies for the treatment of acute and chronic liver diseases.
- Industry Biotechnology Research
- Website https://www.heparegenix.com/
- LinkedIn https://www.linkedin.com/company/heparegenix-gmbh/
Avtal | $24,000,000 | (Mar 20, 2026)
Ezra AI Labs | $3,200,000 | (Mar 20, 2026)
Claros | $30,000,000 | (Mar 20, 2026)
Latent | $80,000,000 | (Mar 20, 2026)
Corridor | $25,000,000 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
Edra | $30,000,000 | (Mar 20, 2026)
Chalkie AI | $4,000,000 | (Mar 20, 2026)
Deeptune | $43,000,000 | (Mar 20, 2026)
Laminar (YC S24) | $3,000,000 | (Mar 19, 2026)